Cargando…
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Drug resistance represents one of the greatest challenges in cancer treatment. Cancer stem cells (CSCs), a subset of cells within the tumor with the potential for self-renewal, differentiation and tumorigenicity, are thought to be the major cause of cancer therapy failure due to their considerable c...
Autores principales: | Prieto-Vila, Marta, Takahashi, Ryou-u, Usuba, Wataru, Kohama, Isaku, Ochiya, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751177/ https://www.ncbi.nlm.nih.gov/pubmed/29194401 http://dx.doi.org/10.3390/ijms18122574 |
Ejemplares similares
-
Development of miRNA‐based therapeutic approaches for cancer patients
por: Takahashi, Ryou‐u, et al.
Publicado: (2019) -
Quercetin Inhibits Lef1 and Resensitizes Docetaxel-Resistant Breast Cancer Cells
por: Prieto-Vila, Marta, et al.
Publicado: (2020) -
Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications
por: Kosaka, Nobuyoshi, et al.
Publicado: (2019) -
CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells
por: Miyazaki, Hiroaki, et al.
Publicado: (2018) -
Transcriptomic Dissection of Hepatocyte Heterogeneity: Linking Ploidy, Zonation, and Stem/Progenitor Cell Characteristics
por: Katsuda, Takeshi, et al.
Publicado: (2019)